Natural STING Agonist as an “Ideal” Adjuvant for Cutaneous Vaccination

Journal of Investigative Dermatology

Volumn 136, Issue 11, 2016, Pages 2183-2191

  Wang, Ji ^a   Li, Peiyu ^a,c   Wu, Mei X ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC GUANOSINE MONOPHOSPHATE ADENOSINE MONOPHOSPHATE; BETA INTERFERON; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHORYL LIPID A; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; AVIAN INFLUENZA (H5N1); CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; DERMATITIS; DRUG SAFETY; GENE; HUMORAL IMMUNITY; INFLUENZA VACCINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STIMULATOR OF INTERFERON GENE; ANIMAL; CUTANEOUS DRUG ADMINISTRATION; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H5N1); INFLUENZA, HUMAN; KNOCKOUT MOUSE; PIG; PROCEDURES; VACCINATION; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ANIMALS; HUMANS; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, KNOCKOUT; SWINE; VACCINATION;

EID: 84994751925     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.05.105     Document Type: Article

References (33)

1. Blaauboer, S.M., Mansouri, S., Tucker, H.R., Wang, H.L., Gabrielle, V.D., Jin, L., The mucosal adjuvant cyclic di-GMP enhances antigen uptake and selectively activates pinocytosis-efficient cells in vivo. Elife, 4, 2015, e06670.
2. Boes, M., Cerny, J., Massol, R., Op, D.B., Kirchhausen, T., Chen, J., et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418 (2002), 983–988.
3. Cai, X., Chiu, Y.H., Chen, Z.J., The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol Cell 54 (2014), 289–296.
4. Calabro, S., Tortoli, M., Baudner, B.C., Pacitto, A., Cortese, M., O'Hagan, D.T., et al. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29 (2011), 1812–1823.
5. Chen, X., Pravetoni, M., Bhayana, B., Pentel, P.R., Wu, M.X., High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants. Vaccine 31 (2012), 159–164.
6. Chen, X., Wang, J., Shah, D., Wu, M.X., An update on the use of laser technology in skin vaccination. Expert Rev Vaccines 12 (2013), 1313–1323.
7. Clegg, C.H., Roque, R., Van Hoeven, N., Perrone, L., Baldwin, S.L., Rininger, J.A., et al. Adjuvant solution for pandemic influenza vaccine production. Proc Natl Acad Sci USA 109 (2012), 17585–17590.
8. Corrales, L., Glickman, L.H., McWhirter, S.M., Kanne, D.B., Sivick, K.E., Katibah, G.E., et al. Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity. Cell Rep 11 (2015), 1018–1030.
9. Ebensen, T., Schulze, K., Riese, P., Link, C., Morr, M., Guzman, C.A., The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties. Vaccine 25 (2007), 1464–1469.
10. Ebensen, T., Schulze, K., Riese, P., Morr, M., Guzman, C.A., The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant. Clin Vaccine Immunol 14 (2007), 952–958.
11. Ginhoux, F., Ng, L.G., Merad, M., Understanding the murine cutaneous dendritic cell network to improve intradermal vaccination strategies. Curr Top Microbiol Immunol 351 (2012), 1–24.
12. Hanson, M.C., Crespo, M.P., Abraham, W., Moynihan, K.D., Szeto, G.L., Chen, S.H., et al. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants. J Clin Invest 125 (2015), 2532–2546.
13. Hickling, J.K., Jones, K.R., Friede, M., Zehrung, D., Chen, D., Kristensen, D., Intradermal delivery of vaccines: Potential benefits and current challenges. Bull World Health Organ 89 (2011), 221–226.
14. Hutchison, S., Benson, R.A., Gibson, V.B., Pollock, A.H., Garside, P., Brewer, J.M., Antigen depot is not required for alum adjuvanticity. FASEB J 26 (2012), 1272–1279.
15. Ishikawa, H., Ma, Z., Barber, G.N., STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461 (2009), 788–792.
16. Jin, L., Waterman, P.M., Jonscher, K.R., Short, C.M., Reisdorph, N.A., Cambier, J.C., MPYS, a novel membrane tetraspanner, is associated with major histocompatibility complex class II and mediates transduction of apoptotic signals. Mol Cell Biol 28 (2008), 5014–5026.
17. Karaolis, D.K., Means, T.K., Yang, D., Takahashi, M., Yoshimura, T., Muraille, E., et al. Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol 178 (2007), 2171–2181.
18. Li, L., Yin, Q., Kuss, P., Maliga, Z., Millan, J.L., Wu, H., et al. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs. Nat Chem Biol 10 (2014), 1043–1048.
19. Li, X.D., Wu, J., Gao, D., Wang, H., Sun, L., Chen, Z.J., Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341 (2013), 1390–1394.
20. MacLeod, M.K., McKee, A.S., David, A., Wang, J., Mason, R., Kappler, J.W., et al. Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells. Proc Natl Acad Sci USA 108 (2011), 7914–7919.
21. Manstein, D., Herron, G.S., Sink, R.K., Tanner, H., Anderson, R.R., Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 34 (2004), 426–438.
22. Muller, U., Steinhoff, U., Reis, L.F., Hemmi, S., Pavlovic, J., Zinkernagel, R.M., et al. Functional role of type I and type II interferons in antiviral defense. Science 264 (1994), 1918–1921.
23. Ogunniyi, A.D., Paton, J.C., Kirby, A.C., McCullers, J.A., Cook, J., Hyodo, M., et al. C-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection. Vaccine 26 (2008), 4676–4685.
24. Paludan, S.R., Bowie, A.G., Immune sensing of DNA. Immunity 38 (2013), 870–880.
25. Reed, S.G., Orr, M.T., Fox, C.B., Key roles of adjuvants in modern vaccines. Nat Med 19 (2013), 1597–1608.
26. Sun, L., Wu, J., Du, F., Chen, X., Chen, Z.J., Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339 (2013), 786–791.
27. Treanor, J.J., Campbell, J.D., Zangwill, K.M., Rowe, T., Wolff, M., Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354 (2006), 1343–1351.
28. Vogelbruch, M., Nuss, B., Korner, M., Kapp, A., Kiehl, P., Bohm, W., Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy 55 (2000), 883–887.
29. Wang, J., Li, B., Wu, M.X., Effective and lesion-free cutaneous influenza vaccination. Proc Natl Acad Sci USA 112 (2015), 5005–5010.
30. Wang, J., Shah, D., Chen, X., Anderson, R.R., Wu, M.X., A micro-sterile inflammation array as an adjuvant for influenza vaccines. Nat Commun, 5, 2014, 4447.
31. Wegmann, F., Gartlan, K.H., Harandi, A.M., Brinckmann, S.A., Coccia, M., Hillson, W.R., et al. Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens. Nat Biotechnol 30 (2012), 883–888.
32. Wu, J., Sun, L., Chen, X., Du, F., Shi, H., Chen, C., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339 (2013), 826–830.
33. Zhong, B., Yang, Y., Li, S., Wang, Y.Y., Li, Y., Diao, F., et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29 (2008), 538–550.